Abstract
The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field in order to standardize producers to assist the reasoning and decision-making of doctors. The information provided through this project must be assessed and criticized by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical status of each patient.
Publication types
-
Meta-Analysis
-
Practice Guideline
-
Systematic Review
MeSH terms
-
Adalimumab / therapeutic use
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Brazil
-
Certolizumab Pegol / therapeutic use
-
Clinical Decision-Making
-
Crohn Disease / drug therapy*
-
Drug Therapy, Combination
-
Humans
-
Infliximab / therapeutic use
-
Remission Induction
-
Time Factors
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
-
Ustekinumab / therapeutic use
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Tumor Necrosis Factor-alpha
-
vedolizumab
-
Infliximab
-
Ustekinumab
-
Adalimumab
-
Certolizumab Pegol